Business Description

Description
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 20.61
9-Day RSI 27.09
14-Day RSI 29.61
6-1 Month Momentum % -99
12-1 Month Momentum % -99

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials

PARD's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:PARD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Poniard Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -12
Beta 23.12
Volatility % 99
14-Day RSI 29.61
14-Day ATR ($) 0.000324
20-Day SMA ($) 0.0001
12-1 Month Momentum % -99
52-Week Range ($) 0.0001 - 0.01
Shares Outstanding (Mil) 1.5

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Poniard Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Poniard Pharmaceuticals Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Poniard Pharmaceuticals Inc Frequently Asked Questions

What is Poniard Pharmaceuticals Inc(PARD)'s stock price today?
The current price of PARD is $0.00. The 52 week high of PARD is $0.01 and 52 week low is $0.00.
When is next earnings date of Poniard Pharmaceuticals Inc(PARD)?
The next earnings date of Poniard Pharmaceuticals Inc(PARD) is .
Does Poniard Pharmaceuticals Inc(PARD) pay dividends? If so, how much?
Poniard Pharmaceuticals Inc(PARD) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1